DE69508913T2 - Pharmazeutische polythioharnstoffe enthaltende formulierungen und methode zu ihrer verwendung - Google Patents

Pharmazeutische polythioharnstoffe enthaltende formulierungen und methode zu ihrer verwendung

Info

Publication number
DE69508913T2
DE69508913T2 DE69508913T DE69508913T DE69508913T2 DE 69508913 T2 DE69508913 T2 DE 69508913T2 DE 69508913 T DE69508913 T DE 69508913T DE 69508913 T DE69508913 T DE 69508913T DE 69508913 T2 DE69508913 T2 DE 69508913T2
Authority
DE
Germany
Prior art keywords
oligomer
oligomers
polythiourea
radical
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69508913T
Other languages
German (de)
English (en)
Other versions
DE69508913D1 (de
Inventor
Alan Cardin
William Fordyce
William Kruper
Michael Mullins
Norton Peet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Chemical Co
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc, Dow Chemical Co filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69508913D1 publication Critical patent/DE69508913D1/de
Application granted granted Critical
Publication of DE69508913T2 publication Critical patent/DE69508913T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69508913T 1994-01-03 1995-01-03 Pharmazeutische polythioharnstoffe enthaltende formulierungen und methode zu ihrer verwendung Expired - Fee Related DE69508913T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17658694A 1994-01-03 1994-01-03
PCT/US1995/000118 WO1995018791A1 (en) 1994-01-03 1995-01-03 Pharmaceutical formulations comprising polythiourea and method of use thereof

Publications (2)

Publication Number Publication Date
DE69508913D1 DE69508913D1 (de) 1999-05-12
DE69508913T2 true DE69508913T2 (de) 1999-12-02

Family

ID=22644965

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69508913T Expired - Fee Related DE69508913T2 (de) 1994-01-03 1995-01-03 Pharmazeutische polythioharnstoffe enthaltende formulierungen und methode zu ihrer verwendung

Country Status (23)

Country Link
US (1) US6086864A (enExample)
EP (1) EP0738261B1 (enExample)
KR (1) KR100362343B1 (enExample)
CN (1) CN1070180C (enExample)
AP (1) AP638A (enExample)
AT (1) ATE178595T1 (enExample)
AU (1) AU693853B2 (enExample)
CA (1) CA2179988C (enExample)
CZ (1) CZ197996A3 (enExample)
DE (1) DE69508913T2 (enExample)
DK (1) DK0738261T3 (enExample)
ES (1) ES2133734T3 (enExample)
FI (1) FI962725A0 (enExample)
GR (1) GR3030521T3 (enExample)
HU (1) HUT74694A (enExample)
IL (1) IL112174A (enExample)
MX (1) MX9602542A (enExample)
NO (1) NO306613B1 (enExample)
NZ (1) NZ279587A (enExample)
OA (1) OA10367A (enExample)
TW (1) TW303377B (enExample)
WO (1) WO1995018791A1 (enExample)
ZA (1) ZA9410408B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6186659B1 (en) * 1998-08-21 2001-02-13 Agilent Technologies Inc. Apparatus and method for mixing a film of fluid
CN105582020B (zh) * 2014-10-21 2019-04-16 浙江大学 一种线形聚硫脲和超支化聚硫脲在制备抗肿瘤药物及抗病毒或抗菌药物中的应用
CN107236128A (zh) * 2017-06-21 2017-10-10 华南理工大学 一种异腈、硫和胺的多组分聚合制备聚硫脲的方法及该聚硫脲的应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE544868A (enExample) *
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US2833744A (en) * 1953-08-27 1958-05-06 Ciba Pharm Prod Inc Polyureas and process of preparing same
US2868834A (en) * 1955-02-01 1959-01-13 Ciba Pharm Prod Inc Manufacture of new polythioureas
US3164571A (en) * 1959-12-31 1965-01-05 Union Carbide Corp Polyureas from n-phenyl, phenylene biscarbamyl halide and a diamine
US3528949A (en) * 1968-05-07 1970-09-15 Atlas Chem Ind Polymers from ureas and dihalides
US3978024A (en) * 1973-12-28 1976-08-31 General Electric Company Flame retardant polycarbonate composition
US4328244A (en) * 1980-05-21 1982-05-04 The Dow Chemical Company Novel (((substituted-phenyl)methyl)amino)benzenesulfonic acids and pharmaceutically-acceptable salts thereof
US4349568A (en) * 1980-06-12 1982-09-14 The Dow Chemical Company Sulfur-substituted diphenyl ethers having antiviral activity
US4435394A (en) * 1981-12-17 1984-03-06 Shionogi & Co., Ltd. 3-Sulfonamido-benzophenonimine derivatives useful for treating virus infections
US4471110A (en) * 1982-08-02 1984-09-11 E. I. Dupont De Nemours And Company Polyamide of disulfonated diamine and permselective membrane thereof
US4824916A (en) * 1985-03-15 1989-04-25 The Dow Chemical Company Water-insoluble, crosslinked, sulfonated aromatic polyamide
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
DE3601136A1 (de) * 1986-01-16 1987-07-23 Max Planck Gesellschaft Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
US4895660A (en) * 1986-07-14 1990-01-23 The Dow Chemical Company Water-soluble aromatic polyamides and polyureas
DE3626309A1 (de) * 1986-08-02 1988-02-18 Stockhausen Chem Fab Gmbh Antivirusmittel
DE3744119A1 (de) * 1987-12-24 1989-07-06 Basf Ag Verwendung von polysulfatierten heparinen
ZA9094B (en) * 1989-01-11 1990-10-31 Merrell Dow Pharma Heparin fraction with anti-hiv activity
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5124149A (en) * 1990-11-07 1992-06-23 The United States Of America As Represented By The Secretary Of Agriculture Compositions and methods for biocontrol using fluorescent brighteners
FR2669535A1 (fr) * 1990-11-26 1992-05-29 Medgenix Group Sa Utilisation a titre de medicament de macromolecules polysulfonees.
DK0498095T3 (da) * 1991-02-05 1995-06-19 Merrell Dow Pharma Sulfoniske stilbenderivater til behandling af virussygdomme
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
NZ249032A (en) * 1992-02-20 1996-09-25 Merrell Dow Pharma Stilbene disulphonic acid derivatives substituted in the 4- and 4'-positions by thioureido, thiocarbonate ester, and thiocarbamate and thiocarbamoyloxy (and -omino) and thioamide groups; use in treating viral diseases

Also Published As

Publication number Publication date
KR100362343B1 (ko) 2003-11-28
NO962782L (no) 1996-09-02
CN1070180C (zh) 2001-08-29
AU1675695A (en) 1995-08-01
AP9600842A0 (en) 1996-07-31
ES2133734T3 (es) 1999-09-16
HU9601813D0 (en) 1996-09-30
NO962782D0 (no) 1996-07-02
ZA9410408B (en) 1995-12-11
FI962725A7 (fi) 1996-07-02
AP638A (en) 1998-04-14
IL112174A (en) 1999-05-09
CN1138323A (zh) 1996-12-18
ATE178595T1 (de) 1999-04-15
DK0738261T3 (da) 1999-10-18
MX9602542A (es) 1997-05-31
NO306613B1 (no) 1999-11-29
CA2179988C (en) 2002-10-29
OA10367A (en) 2001-11-19
DE69508913D1 (de) 1999-05-12
EP0738261A1 (en) 1996-10-23
TW303377B (enExample) 1997-04-21
EP0738261B1 (en) 1999-04-07
NZ279587A (en) 1997-04-24
CA2179988A1 (en) 1995-07-13
US6086864A (en) 2000-07-11
HUT74694A (en) 1997-01-28
FI962725L (fi) 1995-07-02
CZ197996A3 (en) 1996-12-11
GR3030521T3 (en) 1999-10-29
AU693853B2 (en) 1998-07-09
FI962725A0 (fi) 1996-07-02
WO1995018791A1 (en) 1995-07-13
IL112174A0 (en) 1995-03-15

Similar Documents

Publication Publication Date Title
DE69130381T2 (de) Oligomere, ihre Verwendungen sowie Formulierungen
DE69315058T2 (de) Eng poly- und mono-disperse anionische oligomere, ihre verwendungen, formulierungen sowie verfahren
DE69106493T2 (de) Sulfonische Stilbenderivate zur Behandlung von Viruserkrankungen.
EP0703786B1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
DE69318136T2 (de) Sulfonsaeurederivate zur behandlung von viruserkrankungen
DE2600466C2 (de) Verfahren zur Verhinderung des Algenwachstums
DE68921413T2 (de) Verbindungen und Zusammensetzungen zur Anwendung bei Methoden zur Behandlung und Prophylaxe von Pneumocystis Carinii Pneumonia und anderen Krankheiten.
DE69313438T2 (de) Von hydroxylaminen abgeleitete n,n'-substituierte imidocarbonimiddiamide
WO1990004401A1 (en) Supramolecular surfactants: amphiphilic polymers designed to disrupt lipid membranes
DE69508913T2 (de) Pharmazeutische polythioharnstoffe enthaltende formulierungen und methode zu ihrer verwendung
DE68914990T2 (de) Verfahren zur inhibierung der wirkung des menschlichen immunschwäche-virus (hiv) in vivo.
RU2678986C1 (ru) Противовирусное средство на основе гуминовых кислот
JPH09508102A (ja) ポリチオ尿素を含む薬剤処方剤及びその使用方法
UA46163C2 (uk) N, n'-(сульфонілди-1,4-фенілен)біс(n",n"-диметилформамідин)-1,2,3,4-тетрагідро-6-метил-2,4-діоксо-5-піримідинсульфонат, що стимулює клітинний метаболізм і має імунотропну та антимікобактеріальну активність, і спосіб його отримання
US5179190A (en) Supramolecular surfactants: amphiphilic polymers designed to disrupt lipid membranes
EP0007616B1 (de) Isothiocyanobenzthiazolderivat, Verfahren zu seiner Herstellung und seine Anwendung in anthelmintischen Mitteln
EP1669357A4 (en) SUBSTANCE MANIFESTANT ANTIVIRAL AND ANTIBACTERIAL ACTIVITY BASED ON 2,8-DITHIOXO-1H-PYRANO-2,3-D DERIVATIVES; 6,5-D '| DIPYRIMIDINE AND ITS ANALOGUES 10-AZA
DE2143437A1 (de) Arzneimittel zur Bekämpfung von Virusinfektionen und dessen Verwendung als Zusatz zu Futtermitteln
CA2185817A1 (en) Anti-viral and anti-cancer agents
WO1993015607A1 (en) Ion pairs of hypericin compounds having antiviral activity
DE60214578T2 (de) Polymaleinimid-verbindungen und ihre medizinische verwendung
DE1418518A1 (de) Verfahren zur Herstellung von therapeutisch wirksamen Derivaten des Cyclohexadienol-4-ons-1
NO159082B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive phenantrenmetanol-derivater.
DE10129256A1 (de) Antivirale Glykokonjugate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee